Potential for interferon-alpha-based therapy in mesothelioma: assessment in a murine model.
H Bielefeldt-Ohmann, DR Fitzpatrick, AL Marzo, AG Jarnicki, AW Musk, BW Robinson
Journal of Interferon & Cytokine Research | Published : 1995
Malignant mesothelioma is an aggressive tumor, usually induced by asbestos exposure, that has a poor prognosis and is unresponsive to conventional therapy. The present study was aimed at assessing the potential for interferon-alpha (IFN-alpha)-based therapies in a murine model for malignant mesothelioma. The effect of recombinant human IFN-alpha B/D on tumor growth, alone and in combination with either of two immunomodulatory and antiproliferative agents beta-carotene or alpha-difluoromethylornithine (DFMO), was assessed. The data suggest that IFN-alpha treatment is most efficacious when commenced early in tumor development. Combination of IFN-alpha with either DFMO or dietary beta-carotene ..View full abstract